In a nationwide Danish cohort study of 35,845 patients with lichen planus, oral LP was linked to higher oral cancer risk, with oral cavity cancer rates 7.5 times expected in women, tongue cancer 6.8 times expected, and lip cancer 6.0 times expected. The study found the highest cancer risk tracked to the same anatomic site as the LP lesion—making frontline recognition of oral and genital LP especially important for NPs and PAs.

Why It Matters To Your Practice

• LP is not just a benign chronic inflammatory finding: oral and genital disease may signal a long-term site-specific cancer risk.

• You are often the first clinician to see these lesions in primary care, urgent care, dermatology, ENT, oral health, women’s health, or oncology follow-up—so your exam can change the trajectory.

• The signal was consistent in both women and men, and oral LP carried the highest risk for later oral cancers.

Clinical Benefits

• Use every oral exam to look carefully for persistent white, lacy, erosive, or ulcerative lesions that do not fit simple trauma or candidiasis.

• Early recognition can speed referral for biopsy, oral medicine, ENT, dermatology, gynecology, or dental/oral surgery evaluation when lesions persist or look suspicious.

• For patients with known LP, documenting site, symptoms, duration, and interval change helps support smarter surveillance over time.

Managing Risks

• Do not overstate the danger: absolute 20-year risk remained low, including about 0.8% to 1.0% for oral cavity cancer and 0.5% to 0.6% for tongue cancer.

• Still, persistent site-matched lesions deserve respect—especially oral LP and genital LP—because the excess risk clustered where the disease was located.

• Counsel patients on tobacco and alcohol risk reduction, symptom monitoring, and the importance of follow-up if lesions persist, evolve, bleed, ulcerate, or become more painful.

The Bottom Line

• Trust your eye: if oral LP looks chronic, atypical, or progressive, your decision to recheck, document, and refer may be the step that catches cancer earlier.

• Nurse practitioners and physician assistants are not “backup” here—you’re the frontline diagnosticians most likely to spot the lesion that matters before anyone else does.

• Bottom line: LP usually will not progress to cancer, but oral and genital LP warrant vigilance because site-specific malignancy is a real long-term complication.